CHALLENGES IN INITIATION OF TREATMENT OF MULTI DRUG RESISTANT-TB PATIENTS: A HOSPITAL BASED CROSS SECTIONAL STUDY IN JHARKHAND.

Author:

Kumar Ashutosh1,Chandra Keshav2,Kumar Chandramani3,Sunderem Shalini4,Sircar Shubhashish5

Affiliation:

1. Senior Resident, Department of Community Medicine.

2. Junior Resident, Department of Paediatrics ,NMCH Patna

3. Assistant Professor,SBMCH Hazaribag, Department of Community Medicine

4. Professor, RIMS Ranchi, Department of Community Medicine

5. Associate Prof. SBMCH Hazaribag, Department of Community Medicine

Abstract

BACKGROUND: Multi-drug resistant tuberculosis has become major public health problem and obstacle to effective control of tuberculosis. Over a period of time, there are several landmark achievements including policy and system preparedness for universal access to TB care including mandatory notication of TB cases, development of standard for TB care in India, comprehensive real time TB information management system-NIKSHAY, use of rapid molecular diagnostics, successful innovations in private sector engagement for TB care-Universal access to TB care. Objective was to nd out the challenges in initiation of treatment of Multi Drug Resistant-TB patients get admitted in ITKI Sanatorium Ranchi Jharkhand. METHODS: It was a hospital based cross sectional study carried out from August 2016 to Nov.2018 on Multi drug resistant tuberculosis patients admitted in MDR-TB centre Itki Sanatorium Ranchi after approved from institutional ethics committee. Total study subjects included in study was 64. RESULTS: Most of the study subjects 58 (90.6%) did not know about the MDR-TB. Most of the study subjects 40 (62.5%) had been given reports of CB-NAAT test on same day followed by study subjects 24 (37.5%) on alternate day. No one study subjects 64 (100%) had been given any type of incentive for travelling to pretreatment evaluation centre. In above table, most of the patients 51 (79.7%) had made payment for investigations at district hospital/ SDH level followed by 13 (20.3%) who were free of any expenditure for investigations. Most of the study subjects 60 (93.7%) were not visited by any health staff between nal diagnosis of MDR-TB and initiation of treatment for MDR-TB followed by subjects 4 (6.3%) who were being visited by health staff. Most of the study subjects 48 (75%) were unaware about the NIKSHAY POSHAN SCHEME for MDR-TB patients followed by subjects 16 (25%) who knew about the NIKSHAY POSHAN SCHEME for MDR-TB patients by means of various medium.

Publisher

World Wide Journals

Reference7 articles.

1. Chan Margaret (2009)Director-General of the World Health Organization.MDR -TB overcoming resistance in essential opening remarks at the panel on “Funding and implementing innovations” 2009 pacific health summit. Washington in USA 18 June 2009. http://www.who.int/dg/speeches/MDR_tb_resistance_20090618/en/accessed on 21 Nov.2022

2. Stop TB partnership and WHO Geneva (2006) global plan to stop TB 2006-15. http://www.stoptb.org/assets/documents/resources/publications/plan_strategy/the

3. World Health Organization,Geneva 2008 Guidelines for programmatic management of drug resistant tuberculosis; An emergency update (WHO/HTM/T3/2008.402)

4. Ramchandran R, Nalini S, Chandrasekar V,Dave PV,Sanghvi AS, etal.(2009)Surveillance of drug- resistant tuberculosis in the state of Gujarat,India. Int. tuberc Lung dis 13;1154-1160.

5. World Health Organization,Geneva (2010) Multidrug and extensively drug-resistant TB(M/XDR-TB) Global reports on surveillance and response(WHO/HTM/TB/2010.3

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3